IndraLab

Statements

Oclacitinib inhibits TYK2. 1 / 3

2 | 1

reach

"Oclacitinib inhibited JAK1, JAK2, JAK3, and TYK2 by 50% at concentrations (IC 50 's) of 10, 18, 99, and 84nm, respectively."

24495176

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

Oclacitinib inhibits TYK2. 1 / 3

INDRA sources:

Databases

Reading